Search Results for "Mri Peritoneal Carcinomatosis"
Original Source: Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging.
Peritoneal carcinomatosis is usually associated with a poor overall survival rate. Recently, introduction of more aggressive surgical treatment and intraperitoneal chemotherapy appears to significantly increase the overall survival rate for these patients. A detailed preoperative assessment of peritoneal carcinomatosis could be very challenging in the field of imaging, but a new aggressive surgical approach requires an accurate preoperative assessment of the disease. Cross-sectional imaging using CT and MRI...
Matching Channels
Matching News
Scientists at the Oswaldo Cruz Foundation and Federal University of Minas Gerais, led by Dr. Andrea Teixeira-Carvalho and Dr. Monica Cristina de Oliveira, have developed and characterized a circulatin...
pH-sensitive liposomal cisplatin improves peritoneal carcinomatosis treatment without side-effects
(Society for Experimental Biology and Medicine) Scientists at the Oswaldo Cruz Foundation and Federal University of Minas Gerais, led by Dr. Andréa Teixeira-Carvalho and Dr. Mônica Cristina de Olive...
Progression in colorectal carcinomatosis may not rule out cure
NEW YORK (Reuters Health) - Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) from colorectal cancer can be undertaken with a curative...
A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis
Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions
The deterioration of the peritoneal membrane during peritoneal dialysis is a serious problem as it leads to technique failure. The factors that have attracted the most attention as culprits in periton...
Lanreotide helps modestly in malignant bowel obstruction
NEW YORK (Reuters Health) - Palliative therapy with lanreotide may provide some relief for patients with inoperable bowel obstruction due to peritoneal carcinomatosis, European researchers say.
Matching PubMed Articles
Peritoneal carcinomatosis caused by colorectal carcinoma is still considered as the end-stage of disease. A multi-modal therapeutic concept including maximal cytoreduction followed by intraperitoneal...
Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging.
Peritoneal carcinomatosis is usually associated with a poor overall survival rate. Recently, introduction of more aggressive surgical treatment and intraperitoneal chemotherapy appears to significantl...
Peritoneal carcinomatosis after robotic-assisted radical cystectomy.
Among patients with metastatic urothelial cancer of the bladder, 16-25% develop peritoneal carcinomatosis. In the majority of cases peritoneal carcinomatosis is associated with multiple metastatic sit...
BACKGROUND: Perioperative intraperitoneal chemotherapy (PIC) is delivered by intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) and early postoperative intraperitoneal chemotherapy (EPIC...
Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.
Patients with advanced gastric carcinoma, especially peritoneal dissemination, have a poor prognosis. Various treatments have been used for peritoneal dissemination of gastric cancer, but there is no...
